T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Amazon
AMZN
|
$968M |
| 2 |
Starbucks
SBUX
|
$909M |
| 3 |
Hilton Worldwide
HLT
|
$698M |
| 4 |
NiSource
NI
|
$674M |
| 5 |
Becton Dickinson
BDX
|
$621M |
Top Sells
| 1 |
Fortive
FTV
|
$1.08B |
| 2 |
Marvell Technology
MRVL
|
$1.06B |
| 3 |
Thermo Fisher Scientific
TMO
|
$767M |
| 4 |
McKesson
MCK
|
$766M |
| 5 |
Broadcom
AVGO
|
$764M |
Sector Composition
| 1 | Technology | 29.18% |
| 2 | Healthcare | 18.36% |
| 3 | Consumer Discretionary | 13.25% |
| 4 | Industrials | 10.53% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Pacific Biosciences
PACB
$393M
| $10K | ﹤0.01% | 7,299 -4,881,313 | -100% | -$6.69M |
|
677
Veracyte
VCYT
$2.39B
| $10K | ﹤0.01% | +360 | New | +$10K |
|
678
Solventum
SOLV
$12.7B
| $10K | ﹤0.01% | +131 | New | +$10K |
|
679
Schrodinger
SDGR
$1.44B
| $8K | ﹤0.01% | +373 | New | +$8K |
|
|
ADVWW
680
Advantage Solutions Warrant
ADVWW
| $6K | ﹤0.01% | 545,310 | – | – |
|
|
CNTA
681
Centessa Pharmaceuticals
CNTA
$2.25B
| $6K | ﹤0.01% | 401 -1,752,847 | -100% | -$26.2M |
|
682
Biohaven
BHVN
$1.63B
| $5K | ﹤0.01% | 311 -643,635 | -100% | -$10.3M |
|
683
RxSight
RXST
$370M
| $5K | ﹤0.01% | 332 -719,486 | -100% | -$10.8M |
|
684
Quanterix
QTRX
$211M
| $4K | ﹤0.01% | +455 | New | +$4K |
|
685
Aaon
AAON
$6.76B
| – | – | -22,314 | Closed | -$1.74M |
|
686
Acadia Healthcare
ACHC
$2.12B
| – | – | -949,569 | Closed | -$28.8M |
|
687
Agree Realty
ADC
$8.05B
| – | – | -380,107 | Closed | -$29.3M |
|
688
Ametek
AME
$42.7B
| – | – | -33,126 | Closed | -$5.7M |
|
689
Apple Hospitality REIT
APLE
$3.1B
| – | – | -6,401,005 | Closed | -$82.6M |
|
690
AppFolio
APPF
$9.94B
| – | – | -8,639 | Closed | -$1.9M |
|
691
Arvinas
ARVN
$568M
| – | – | -548,104 | Closed | -$3.85M |
|
|
BPMC
692
DELISTED
Blueprint Medicines
BPMC
| – | – | -1,302,810 | Closed | -$115M |
|
693
Braze
BRZE
$2.93B
| – | – | -63,027 | Closed | -$2.28M |
|
694
Conagra Brands
CAG
$9.16B
| – | – | -9,152 | Closed | -$245K |
|
695
Capitol Federal Financial
CFFN
$844M
| – | – | -6,593,678 | Closed | -$36.9M |
|
696
Cognex
CGNX
$7.38B
| – | – | -6,082,319 | Closed | -$181M |
|
697
Columbia Financial
CLBK
$1.58B
| – | – | -951,930 | Closed | -$14.3M |
|
698
Coca-Cola Consolidated
COKE
$10.2B
| – | – | -849 | Closed | -$1.15M |
|
699
Carlisle Companies
CSL
$16.5B
| – | – | -836 | Closed | -$285K |
|
700
Dover
DOV
$24.5B
| – | – | -2,050 | Closed | -$361K |
|